Cargando…
Pipeline for specific subtype amplification and drug resistance detection in hepatitis C virus
BACKGROUND: Despite the high sustained virological response rates achieved with current directly-acting antiviral agents (DAAs) against hepatitis C virus (HCV), around 5–10% of treated patients do not respond to current antiviral therapies, and basal resistance to DAAs is increasingly detected among...
Autores principales: | Soria, María Eugenia, Gregori, Josep, Chen, Qian, García-Cehic, Damir, Llorens, Meritxell, de Ávila, Ana I., Beach, Nathan M., Domingo, Esteban, Rodríguez-Frías, Francisco, Buti, María, Esteban, Rafael, Esteban, Juan Ignacio, Quer, Josep, Perales, Celia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122477/ https://www.ncbi.nlm.nih.gov/pubmed/30176817 http://dx.doi.org/10.1186/s12879-018-3356-6 |
Ejemplares similares
-
Baseline hepatitis C virus resistance-associated substitutions present at frequencies lower than 15% may be clinically significant
por: Perales, Celia, et al.
Publicado: (2018) -
New real-time-PCR method to identify single point mutations in hepatitis C virus
por: Chen, Qian, et al.
Publicado: (2016) -
Study of Quasispecies Complexity and Liver Damage Progression after Liver Transplantation in Hepatitis C Virus Infected Patients
por: Llorens-Revull, Meritxell, et al.
Publicado: (2021) -
Rare haplotype load as marker for lethal mutagenesis
por: Gregori, Josep, et al.
Publicado: (2018) -
Resistance of Hepatitis C Virus to Inhibitors: Complexity and Clinical Implications
por: Perales, Celia, et al.
Publicado: (2015)